跳到正文
Dr. Antonio Calles 🫁🚭· @Tony_Calles · X·· 1 天前评分45

#LCSM

正文 · 原文

🧬 @LeXiuning giving a comprehensive discussion of ctDNA dynamics and adaptive intensification regimen in patients with EGFRmut lung cancer.
Bottom line: combination regimens are default in first-line. #ESMO26 #LCSM

158 浏览 · 4 赞 · 2 转发 · 0 回复

来源:Dr. Antonio Calles 🫁🚭 · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org